drugset / Trial / NCT00017628

Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis

NCT00017628

Phase 1 Completed 20 enrolled Northwestern Memorial Hospital
Treatment

Summary

OBJECTIVES: I. Determine the efficacy, in terms of disease progression, of high-dose cyclophosphamide and total body irradiation with T lymphocyte-depleted autologous peripheral blood stem cell or bone marrow rescue in patients with multiple sclerosis.

Timeline

Start
2001-04
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified Intravenous
Background Methylprednisolone Other / unclassified Intravenous
Background filgrastim Protein / enzyme biologic Subcutaneous

Indications